Active

SIMBIOSIS.LIFE

Switched

BE0818008225

Rechtspersoon Private limited company 1 establishment

Dalialaan 7, 2470 Retie Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Active for

17 year

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.

Gross margin

€ -7,220

▲ 70% vs 2024

Profit

Caution

€ -3,690

▲ 90% vs 2024

Debts

Low

€ 10,182

▼ 10% vs 2024

SIMBIOSIS.LIFE from Retie, company number BE0818008225, closed financial year 2025 with a result of € -3,690 after tax. For that financial year SIMBIOSIS.LIFE recorded a gross margin of € -7,220 and equity of € 479,908. Compared with financial year 2024, the result moved from € -35,609 to € -3,690. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What happened at SIMBIOSIS.LIFE?

What happened at SIMBIOSIS.LIFE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 3,690. Source: NBB ↗
  • Marina Cools became a director. NBB
  • Johan Geysen became a director. NBB
  • New establishment in Retie. KBO
  • Start of the company according to the CBE. KBO

In short

From € 78,792 profit in 2021 to € 3,690 loss in 2025.

Paid € 70,144 in corporate taxes since 2021.

Best year ever: 2022, with € 79,179 profit.

Paid out € 49,466 in dividends to the owners in total.

A new publication or filing at SIMBIOSIS.LIFE? We notify you, reason included.

Follow SIMBIOSIS.LIFE

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Marina Cools
Johan Geysen
SIMBIOSIS.LIFE

Behind SIMBIOSIS.LIFE are Marina Cools and Johan Geysen. The same people are also behind PROGRESS PHARMA.

See the full network in the app

Directors

According to the 2025 annual accounts

Marina Cools

Director

Also active at: PROGRESS PHARMA

since 2023

Johan Geysen

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Dalialaan 7

2470 Retie

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0818.008.225
VAT number
BE 0818.008.225
Registered office
Dalialaan 7, 2470 Retie
Names & denominations
SIMBIOSIS.LIFE
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
25 August 2009
Peppol
Active · Active since 24 Nov 2023
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Literaire creatie

Activiteiten van beroepsorganisaties

Scheppende kunsten, m.u.v. ondersteunende diensten

Frequently asked questions

What is the enterprise number of SIMBIOSIS.LIFE?
The enterprise number of SIMBIOSIS.LIFE is BE0818008225.
What is the address of SIMBIOSIS.LIFE?
The registered office of SIMBIOSIS.LIFE is located at Dalialaan 7, 2470 Retie.
When was SIMBIOSIS.LIFE founded?
SIMBIOSIS.LIFE was founded on 25 August 2009.
What is the main activity of SIMBIOSIS.LIFE?
The main activity of SIMBIOSIS.LIFE is "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies" (NACE code 70200).
Does SIMBIOSIS.LIFE have a website?
No website is currently known for SIMBIOSIS.LIFE.
How much profit did SIMBIOSIS.LIFE make in 2025?
SIMBIOSIS.LIFE recorded a loss after taxes of € 3,690 in financial year 2025.
What is the revenue of SIMBIOSIS.LIFE?
As a small company, SIMBIOSIS.LIFE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -7,220.
Where can I find the annual accounts of SIMBIOSIS.LIFE?
SIMBIOSIS.LIFE files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of SIMBIOSIS.LIFE?
According to the 2025 annual accounts, the directors of SIMBIOSIS.LIFE are: Marina Cools, Johan Geysen.
Who owns SIMBIOSIS.LIFE?
Behind SIMBIOSIS.LIFE are Marina Cools and Johan Geysen. The same people are also behind PROGRESS PHARMA.